This study is looking at whether transcranial magnetic stimulation (TMS) can help young people aged 12-20 who still have symptoms of post-traumatic stress disorder (PTSD) after completing talk therapy. TMS uses magnetic pulses to stimulate specific areas of the brain. The study will involve 20 participants and aims to see if TMS is a safe and helpful treatment. We will measure side effects, adverse events, and how many participants complete the treatment. To join, you must be 12-20 years old, have completed at least 9 sessions of trauma-focused therapy, and have a current self-reported PTSD symptom score of 20 or higher on the UCLA PTSD Reaction Index. You also need to be willing to attend 10 TMS treatment sessions within 30 days and be fluent in English. The current status of this study is unclear.

Study design

This is an interventional study planning to enroll 20 participants. It will test the MagPro R30 with robotic arm device.

What's involved

You would be involved in the study for about 16 weeks, attending approximately 6 research visits and 10 treatment visits. Some research visits can be completed virtually.

Compensation

Not stated in the trial record.

Follow-up

Side effects, adverse events, and treatment completion will be measured from Day 1 of treatment through Day 30.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.